scispace - formally typeset
R

Robert Uldall

Researcher at University of Toronto

Publications -  11
Citations -  940

Robert Uldall is an academic researcher from University of Toronto. The author has contributed to research in topics: Jugular vein & Hemodialysis. The author has an hindex of 8, co-authored 11 publications receiving 932 citations.

Papers
More filters
Journal ArticleDOI

Nocturnal hemodialysis: three-year experience.

TL;DR: Nocturnal hemodialysis represents the most efficient form of dialysis at low cost and should be considered as an option for patients who can be trained for home he modialysis.
Journal ArticleDOI

Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis

TL;DR: NHD is more effective in controlling serum phosphate levels than CHD, allowing patients to discontinue their phosphate binders completely and to ingest a more liberal diet.
Journal ArticleDOI

A new vascular access catheter for hemodialysis.

TL;DR: A new vascular access catheter has been developed that is suitable for both short-term and long-term hemodialysis and should be possible to stop the subclavian vein damage and perforating injuries that have been the most important complications of semistiff, tapered, subClavian catheters.
Journal ArticleDOI

Percutaneously inserted silastic jugular hemodialysis catheters seldom cause jugular vein thrombosis.

TL;DR: The authors conclude that percutaneous internal jugular vein cannulation for hemodialysis access causes an acceptably low incidence of jugular veins damage, which strengthens the case for preferential use of the internal jugul vein for vascular access in patients with end‐stage renal failure and suggests that per cutaneous cannulation is less damaging than surgical insertion.
Journal ArticleDOI

Superior Vena Cava Stenosis Associated With Hemodialysis Catheters

TL;DR: Stenosis of the superior vena cava should be suspected when jugular catheters in the SVC give inadequate flows in the absence of thrombotic obstruction, and balloon dilatation with or without vascular stenting may allow satisfactory vascular access to be reestablished.